These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 25689415

  • 41. Targeting the endocannabinoid system in the amygdala kindling model of temporal lobe epilepsy in mice.
    Wendt H, Soerensen J, Wotjak CT, Potschka H.
    Epilepsia; 2011 Jul; 52(7):e62-5. PubMed ID: 21627644
    [Abstract] [Full Text] [Related]

  • 42. Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice.
    Naderi N, Aziz Ahari F, Shafaghi B, Najarkolaei AH, Motamedi F.
    J Neural Transm (Vienna); 2008 Nov; 115(11):1501-11. PubMed ID: 18575801
    [Abstract] [Full Text] [Related]

  • 43. Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVD-hemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ1-42-treated mice.
    Zhang RS, He Z, Jin WD, Wang R.
    Neurobiol Learn Mem; 2016 Oct; 134 Pt B():264-74. PubMed ID: 27481221
    [Abstract] [Full Text] [Related]

  • 44. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
    Danandeh A, Vozella V, Lim J, Oveisi F, Ramirez GL, Mears D, Wynn G, Piomelli D.
    Psychopharmacology (Berl); 2018 Nov; 235(11):3211-3221. PubMed ID: 30251159
    [Abstract] [Full Text] [Related]

  • 45. Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates.
    Kangas BD, Leonard MZ, Shukla VG, Alapafuja SO, Nikas SP, Makriyannis A, Bergman J.
    J Pharmacol Exp Ther; 2016 Apr; 357(1):125-33. PubMed ID: 26826191
    [Abstract] [Full Text] [Related]

  • 46. Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease.
    Celorrio M, Fernández-Suárez D, Rojo-Bustamante E, Echeverry-Alzate V, Ramírez MJ, Hillard CJ, López-Moreno JA, Maldonado R, Oyarzábal J, Franco R, Aymerich MS.
    Brain Behav Immun; 2016 Oct; 57():94-105. PubMed ID: 27318096
    [Abstract] [Full Text] [Related]

  • 47. Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours.
    Roohbakhsh A, Keshavarz S, Hasanein P, Rezvani ME, Moghaddam AH.
    Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):333-8. PubMed ID: 19614892
    [Abstract] [Full Text] [Related]

  • 48. Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory.
    Clarke JR, Rossato JI, Monteiro S, Bevilaqua LR, Izquierdo I, Cammarota M.
    Neurobiol Learn Mem; 2008 Sep; 90(2):374-81. PubMed ID: 18524639
    [Abstract] [Full Text] [Related]

  • 49. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis.
    Hasanein P, Shahidi S, Komaki A, Mirazi N.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):132-5. PubMed ID: 18593578
    [Abstract] [Full Text] [Related]

  • 50. Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints.
    Krustev E, Reid A, McDougall JJ.
    Arthritis Res Ther; 2014 Sep 27; 16(5):437. PubMed ID: 25260980
    [Abstract] [Full Text] [Related]

  • 51. Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats.
    Trezza V, Damsteegt R, Manduca A, Petrosino S, Van Kerkhof LW, Pasterkamp RJ, Zhou Y, Campolongo P, Cuomo V, Di Marzo V, Vanderschuren LJ.
    J Neurosci; 2012 Oct 24; 32(43):14899-908. PubMed ID: 23100412
    [Abstract] [Full Text] [Related]

  • 52. Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests.
    Burgos E, Pascual D, Martín MI, Goicoechea C.
    Eur J Pain; 2010 Jan 24; 14(1):40-8. PubMed ID: 19318283
    [Abstract] [Full Text] [Related]

  • 53. GABA(A) receptors in the central amygdala are involved in memory retention deficits induced by cannabinoids in rats.
    Hasanein P, Sharifi M.
    Pharmacol Biochem Behav; 2015 Nov 24; 138():26-31. PubMed ID: 26368844
    [Abstract] [Full Text] [Related]

  • 54. Inhibition of fatty acid amide hydrolase produces PPAR-alpha-mediated analgesia in a rat model of inflammatory pain.
    Sagar DR, Kendall DA, Chapman V.
    Br J Pharmacol; 2008 Dec 24; 155(8):1297-306. PubMed ID: 18724387
    [Abstract] [Full Text] [Related]

  • 55. Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behavior in rats.
    Pattij T, Janssen MC, Schepers I, González-Cuevas G, de Vries TJ, Schoffelmeer AN.
    Psychopharmacology (Berl); 2007 Jul 24; 193(1):85-96. PubMed ID: 17387457
    [Abstract] [Full Text] [Related]

  • 56. Normal aging in rats and pathological aging in human Alzheimer's disease decrease FAAH activity: modulation by cannabinoid agonists.
    Pascual AC, Martín-Moreno AM, Giusto NM, de Ceballos ML, Pasquaré SJ.
    Exp Gerontol; 2014 Dec 24; 60():92-9. PubMed ID: 25456842
    [Abstract] [Full Text] [Related]

  • 57. Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine.
    Vlachou S, Stamatopoulou F, Nomikos GG, Panagis G.
    Int J Neuropsychopharmacol; 2008 Nov 24; 11(7):905-23. PubMed ID: 18377702
    [Abstract] [Full Text] [Related]

  • 58. WIN55,212-2 impairs non-associative recognition and spatial memory in rats via CB1 receptor stimulation.
    Galanopoulos A, Polissidis A, Georgiadou G, Papadopoulou-Daifoti Z, Nomikos GG, Pitsikas N, Antoniou K.
    Pharmacol Biochem Behav; 2014 Sep 24; 124():58-66. PubMed ID: 24867078
    [Abstract] [Full Text] [Related]

  • 59. Pharmacological blockade of fatty acid amide hydrolase (FAAH) by URB597 improves memory and changes the phenotype of hippocampal microglia despite ethanol exposure.
    Rivera P, Fernández-Arjona MDM, Silva-Peña D, Blanco E, Vargas A, López-Ávalos MD, Grondona JM, Serrano A, Pavón FJ, Rodríguez de Fonseca F, Suárez J.
    Biochem Pharmacol; 2018 Nov 24; 157():244-257. PubMed ID: 30098312
    [Abstract] [Full Text] [Related]

  • 60. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.
    Mulè F, Amato A, Baldassano S, Serio R.
    Pharmacol Res; 2007 Aug 24; 56(2):132-9. PubMed ID: 17574859
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.